Fexuprazan Hydrochloride

็›้…ธ่ฒไผ˜ๆ‹‰็”Ÿ

Report date: 2025/11/20 15:23:45
NME

Base Information

Drug NameFexuprazan Hydrochloride
Drug Alias NameAbeprazan้ž่‹ๆ‹‰่ตžFexuprazan็›้…ธ้ž่‹ๆ‹‰็”ŸDWP-14012 Hydrochloride +[11]ย 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPotassium-transporting ATPase inhibitors
TargetsPotassium-transporting ATPase
Therapy Area/IndicationsHelicobacter pylori infectionPeptic UlcerGastritis +[6]ย 
Global Approved IndicationsEsophagitis, PepticGastroesophageal Reflux
Approved Indications in ChinaEsophagitis, Peptic
Original Approved Country/TerritorySouth Korea
Original Approved Date2022/07/01
Country/TerritoryPhilippinesSouth KoreaIndonesia +[4]ย 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesDaewoong Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsHelicobacter pylori infectionPeptic UlcerGastritis +[6]ย 
Inactive IndicationsN/A

Other Information

ATC CodeA02BC
Related LinksDrugBank